{"id":532724,"date":"2021-08-31T08:08:14","date_gmt":"2021-08-31T12:08:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/"},"modified":"2021-08-31T08:08:14","modified_gmt":"2021-08-31T12:08:14","slug":"phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/","title":{"rendered":"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n MARLBOROUGH, Mass.<\/span>, Aug. 31, 2021<\/span> \/PRNewswire\/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that new data in support of upcoming clinical studies is scheduled to be presented at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held from September 16-21, 2021<\/span>. <\/p>\n

Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg<\/a><\/p>\n

\n\n\n\n\n\n\n\n
\n

\n
\n Details are as follows:<\/u>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Event: <\/span>\n <\/p>\n<\/td>\n

\n

\n ESMO Virtual Congress 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Title: <\/span>\n <\/p>\n<\/td>\n

\n

\n Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo<\/i> following complete resolution of tumors\u00a0 <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Authors:\u00a0 <\/span>\n <\/p>\n<\/td>\n

\n

\n Benjamin Cuiffo, et al.<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Abstract Number: <\/span>\n <\/p>\n<\/td>\n

\n

\n #4154 <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Date: <\/span>\n <\/p>\n<\/td>\n

\n

\n September 16-21, 2021 <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

An archived version of the Phio presentation will be made available on the “Investors \u2013 Events and Presentations” section of the Company’s website (click here)<\/a><\/u>.<\/p>\n

\n About\u00a0Phio Pharmaceuticals Corp.<\/b>\n <\/p>\n

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL\u2122) therapeutic platform. The Company’s efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environment. Our goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities. For additional information, visit the Company’s website, www.phiopharma.com<\/a>. <\/p>\n

\n Forward Looking Statements<\/b>\n <\/p>\n

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “intends,” “believes,” “anticipates,” “indicates,” “plans,” “expects,” “suggests,” “may,” “would,” “should,” “potential,” “designed to,” “will,” “ongoing,” “estimate,” “forecast,” “target,” “predict,” “could” and similar references, although not all forward-looking statements contain these words. Forward-looking statements are neither historical facts nor assurances of future performance. These statements are based only on our current beliefs, expectations and assumptions regarding the\u00a0 future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements as a result of a number of important factors, including, but not limited to, the impact to our business and operations by the ongoing coronavirus pandemic, the development of our product candidates, our ability to develop our product candidates with collaboration partners, and the success of any such collaborations, the timeline and duration for advancing our product candidates into clinical development, results from our preclinical and clinical activities, the timing or likelihood of regulatory filings and approvals, our ability to manufacture and supply our product candidates for clinical activities and for commercial use if approved, the scope of protection we are able to establish and maintain for intellectual property rights covering our technology platform, our ability to obtain future financing, market and other conditions and those identified in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption “Risk Factors” and in other filings the Company periodically makes with the\u00a0SEC. Readers are urged to review these risk factors and to not act in reliance on any forward-looking statements, as actual results may differ from those contemplated by our forward-looking statements. Phio does not undertake to update forward-looking statements to reflect a change in its views, events or circumstances that occur after the date of this release, except as required by law.<\/p>\n

\n Contact Phio Pharmaceuticals Corp<\/b>.
ir@phiopharma.com<\/a>\u00a0<\/p>\n

\n Investor Contact
<\/b>Ashley R. Robinson\u00a0
LifeSci Advisors
arr@lifesciadvisors.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021-301365371.html<\/a><\/p>\n

SOURCE Phio Pharmaceuticals Corp.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire MARLBOROUGH, Mass., Aug. 31, 2021 \/PRNewswire\/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that new data in support of upcoming clinical studies is scheduled to be presented at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held from September 16-21, 2021. Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg Details are as follows: Event: ESMO Virtual Congress 2021 Title: Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo following complete resolution of tumors\u00a0 Authors:\u00a0 Benjamin Cuiffo, et al. Abstract Number: #4154 Date: September 16-21, 2021 An archived version of the Phio presentation will … <\/p>\n

Continue reading “Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-532724","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPhio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MARLBOROUGH, Mass., Aug. 31, 2021 \/PRNewswire\/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that new data in support of upcoming clinical studies is scheduled to be presented at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held from September 16-21, 2021. Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg Details are as follows: Event: ESMO Virtual Congress 2021 Title: Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo following complete resolution of tumors\u00a0 Authors:\u00a0 Benjamin Cuiffo, et al. Abstract Number: #4154 Date: September 16-21, 2021 An archived version of the Phio presentation will … Continue reading "Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-31T12:08:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE90129&sd=2021-08-31\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021\",\"datePublished\":\"2021-08-31T12:08:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/\"},\"wordCount\":646,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE90129&sd=2021-08-31\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/\",\"name\":\"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE90129&sd=2021-08-31\",\"datePublished\":\"2021-08-31T12:08:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE90129&sd=2021-08-31\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE90129&sd=2021-08-31\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/","og_locale":"en_US","og_type":"article","og_title":"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 - Market Newsdesk","og_description":"PR Newswire MARLBOROUGH, Mass., Aug. 31, 2021 \/PRNewswire\/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that new data in support of upcoming clinical studies is scheduled to be presented at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held from September 16-21, 2021. Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg Details are as follows: Event: ESMO Virtual Congress 2021 Title: Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo following complete resolution of tumors\u00a0 Authors:\u00a0 Benjamin Cuiffo, et al. Abstract Number: #4154 Date: September 16-21, 2021 An archived version of the Phio presentation will … Continue reading \"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-31T12:08:14+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE90129&sd=2021-08-31","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021","datePublished":"2021-08-31T12:08:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/"},"wordCount":646,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE90129&sd=2021-08-31","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/","name":"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE90129&sd=2021-08-31","datePublished":"2021-08-31T12:08:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE90129&sd=2021-08-31","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE90129&sd=2021-08-31"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/532724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=532724"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/532724\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=532724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=532724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=532724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}